193 related articles for article (PubMed ID: 22226230)
1. Colorectal neoplasia in PSC-IBD patients: are times changing?
Sokol H; Chazouilleres O
Liver Int; 2012 Feb; 32(2):175-6. PubMed ID: 22226230
[No Abstract] [Full Text] [Related]
2. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer.
Broomé U; Bergquist A
Semin Liver Dis; 2006 Feb; 26(1):31-41. PubMed ID: 16496231
[TBL] [Abstract][Full Text] [Related]
3. Colonic neoplasia in young patients with inflammatory bowel disease and primary sclerosing cholangitis.
Imam MH; Thackeray EW; Lindor KD
Colorectal Dis; 2013 Feb; 15(2):198-203. PubMed ID: 22712545
[TBL] [Abstract][Full Text] [Related]
4. Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease.
Torres J; Pineton de Chambrun G; Itzkowitz S; Sachar DB; Colombel JF
Aliment Pharmacol Ther; 2011 Sep; 34(5):497-508. PubMed ID: 21692821
[TBL] [Abstract][Full Text] [Related]
5. Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study.
Jørgensen KK; Lindström L; Cvancarova M; Castedal M; Friman S; Schrumpf E; Foss A; Isoniemi H; Nordin A; Holte K; Rasmussen A; Bergquist A; Vatn MH; Boberg KM
Scand J Gastroenterol; 2012 Sep; 47(8-9):1021-9. PubMed ID: 22577871
[TBL] [Abstract][Full Text] [Related]
6. Relationship of inflammatory bowel disease and primary sclerosing cholangitis.
Fausa O; Schrumpf E; Elgjo K
Semin Liver Dis; 1991 Feb; 11(1):31-9. PubMed ID: 2047887
[TBL] [Abstract][Full Text] [Related]
7. In PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survival.
Rudolph G; Gotthardt D; Kloeters-Plachky P; Rost D; Kulaksiz H; Stiehl A
J Hepatol; 2010 Aug; 53(2):313-7. PubMed ID: 20472317
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
[TBL] [Abstract][Full Text] [Related]
9. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
de Vries AB; Janse M; Blokzijl H; Weersma RK
World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965
[TBL] [Abstract][Full Text] [Related]
10. Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease.
Ananthakrishnan AN; Cagan A; Gainer VS; Cheng SC; Cai T; Szolovits P; Shaw SY; Churchill S; Karlson EW; Murphy SN; Kohane I; Liao KP
J Crohns Colitis; 2014 Sep; 8(9):956-63. PubMed ID: 24559536
[TBL] [Abstract][Full Text] [Related]
11. Review article: The relevance of surveillance endoscopy in long-lasting inflammatory bowel disease.
Vleggaar FP; Lutgens MW; Claessen MM
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():47-52. PubMed ID: 18081648
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory Bowel Disease Phenotype in Pediatric Primary Sclerosing Cholangitis.
Lascurain L; Jensen MK; Guthery SL; Holmen J; Deneau M
Inflamm Bowel Dis; 2016 Jan; 22(1):146-50. PubMed ID: 26619054
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota.
Jess T; Loftus EV; Velayos FS; Winther KV; Tremaine WJ; Zinsmeister AR; Scott Harmsen W; Langholz E; Binder V; Munkholm P; Sandborn WJ
Am J Gastroenterol; 2007 Apr; 102(4):829-36. PubMed ID: 17222314
[TBL] [Abstract][Full Text] [Related]
14. Immune-mediated diseases in primary sclerosing cholangitis.
Lamberts LE; Janse M; Haagsma EB; van den Berg AP; Weersma RK
Dig Liver Dis; 2011 Oct; 43(10):802-6. PubMed ID: 21700515
[TBL] [Abstract][Full Text] [Related]
15. Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: a review of the literature.
Wang R; Leong RW
World J Gastroenterol; 2014 Jul; 20(27):8783-9. PubMed ID: 25083052
[TBL] [Abstract][Full Text] [Related]
16. [Primary sclerosing cholangitis].
Boonstra K; Ponsioen CI; Rauws EA; Beuers U
Ned Tijdschr Geneeskd; 2010; 154():A1476. PubMed ID: 20619015
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of inflammatory bowel disease in patients with primary sclerosing cholangitis.
Osmanoğlu N; Tekin F; Ozütemiz O; Ersöz G; Tekeşin O
Turk J Gastroenterol; 2005 Dec; 16(4):240-1. PubMed ID: 16547857
[No Abstract] [Full Text] [Related]
18. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis.
Loftus EV; Harewood GC; Loftus CG; Tremaine WJ; Harmsen WS; Zinsmeister AR; Jewell DA; Sandborn WJ
Gut; 2005 Jan; 54(1):91-6. PubMed ID: 15591511
[TBL] [Abstract][Full Text] [Related]
19. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
Bayraktar Y; Arslan S; Saglam F; Uzunalimoglu B; Kayhan B
Hepatogastroenterology; 1998; 45(24):2064-72. PubMed ID: 9951867
[TBL] [Abstract][Full Text] [Related]
20. Primary Sclerosing Cholangitis: What the Gastroenterologist and Hepatologist Needs to Know.
Gossard AA; Gores GJ
Clin Liver Dis; 2017 Nov; 21(4):725-737. PubMed ID: 28987259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
